Andrea Raffaele Munafo
Overview
Explore the profile of Andrea Raffaele Munafo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Paolisso P, Belmonte M, Gallinoro E, Scarsini R, Bergamaschi L, Portolan L, et al.
Cardiovasc Diabetol
. 2025 Jan;
24(1):14.
PMID: 39806470
No abstract available.
2.
Mandurino-Mirizzi A, Munafo A, Rizzo F, Raone L, Germinal R, Germinal F, et al.
Int J Cardiol
. 2025 Jan;
422:132936.
PMID: 39743143
Background: The results of randomized clinical trials comparing the outcomes of different strategies for driving PCI are mixed, and it remains unclear which technique for driving PCI offers the greatest...
3.
Paolisso P, Belmonte M, Gallinoro E, Scarsini R, Bergamaschi L, Portolan L, et al.
Cardiovasc Diabetol
. 2024 Nov;
23(1):420.
PMID: 39574095
Background: A substantial number of patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI) experience adverse events after TAVI, with health care expenditure. We aimed to investigate...
4.
Munafo A, Ferlini M, Varbella F, Delnevo F, Solli M, Trabattoni D, et al.
Am J Cardiol
. 2024 Oct;
233:55-61.
PMID: 39357617
In patients with recent acute coronary syndromes (ACS), current guidelines recommend a low-density lipoprotein cholesterol (LDL-C) level <55 mg/100 ml. Despite the widespread use of different potent lipid-lowering therapies (LLT),...
5.
Poletti E, Dens J, Egred M, Munafo A, Castaldi G, De Cock E, et al.
Am J Cardiol
. 2024 Jun;
226():24-33.
PMID: 38885921
Chronic total occlusions (CTOs) are frequent in patients with previous coronary artery bypass graft (CABG) surgery. Percutaneous coronary intervention (PCI) is the usual revascularization strategy. Whether or not the presence...
6.
Munafo A, Montalto C, Franzino M, Pistelli L, Di Bella G, Ferlini M, et al.
Eur Heart J Cardiovasc Pharmacother
. 2023 Aug;
9(8):709-721.
PMID: 37634083
Aims: To summarize the totality of evidence validating the Predicting Bleeding Complications in Patients Undergoing Stent Implantation and Subsequent Dual Antiplatelet Therapy (PRECISE-DAPT) score, ascertaining its aggregate discrimination and validation...
7.
Munafo A, Scotti A, Estevez-Loureiro R, Adamo M, Hernandez A, Peregrina E, et al.
Int J Cardiol
. 2023 Jun;
390:131139.
PMID: 37355239
Background: In the first report from the MitraBridge registry, MitraClip as a bridge to heart transplantation (HTx) proved to be at 1-year an effective treatment strategy for 119 patients with...
8.
Tusa M, Popolo Rubbio A, Sisinni A, Borin A, Barletta M, Grasso C, et al.
Am J Cardiol
. 2023 Jun;
200:178-187.
PMID: 37331223
Despite the growing experience with MitraClip in the broad spectrum of mitral regurgitation (MR), limited data are available regarding the independent prognostic role on survival of different mitral regurgitation etiology...
9.
Munafo A, Turco A, Ferlini M, Benzoni G, Cattadori B, Pellegrini C, et al.
Am J Cardiol
. 2022 Nov;
188:7-14.
PMID: 36446228
Although several studies have previously reported on the efficacy of percutaneous coronary intervention (PCI) with first-generation drug-eluting stents (DES) in heart transplant patients with cardiac allograft vasculopathy, few data regarding...
10.
Montalto C, Munafo A, Arzuffi L, Soriano F, Mangieri A, Nava S, et al.
Eur Heart J Open
. 2022 Sep;
2(4):oeac043.
PMID: 36117948
Aims: As the indications to transcatheter aortic valve replacement (TAVR) expand to patients at increasingly lower risk, procedure-related vascular and bleeding complications events must be minimized. We aimed to evaluate...